GlassScriptPhysician profile
Andrea C Torres
NPI 1588831424
$11,348.22
in general payments reported to CMS, 2019-2025
59 companies · $2,802 in 2025
The $2,802 reported for 2025 was more than what 82% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,088 · 2020: $306 · 2021: $12.92 · 2022: $133 · 2023: $1,580 · 2024: $3,425 · 2025: $2,802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,808.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valeritas, INC. | $1,819.07 | 2019 | |
| Lilly USA, LLC | $864.85 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $798.45 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Dexcom, INC. | $624.69 | 2019-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $527.24 | 2019-2025 | |
| Corcept Therapeutics | $519.54 | 2019-2025 | Korlym |
| Amgen INC. | $478.02 | 2019-2025 | Tepezza, Evenity, Prolia |
| Tandem Diabetes Care, INC. | $347.26 | 2020-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Bayer Healthcare Pharmaceuticals INC. | $294.69 | 2023-2025 | |
| Esperion Therapeutics, INC. | $290.24 | 2023-2025 | Nexletol, Nexlizet |
| Beta Bionics, INC. | $278.99 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Radius Health, INC. | $274.44 | 2019-2025 | Tymlos |
| Amneal Pharmaceuticals LLC | $268.84 | 2023-2025 | Unithroid |
| Xeris Pharmaceuticals, INC. | $263.01 | 2023-2025 | Recorlev, Gvoke Hypopen |
| Insulet Corporation | $257.83 | 2019-2024 | Omnipod |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $244.30 | 2024-2025 | Veozah |
| Intuity Medical INC | $218.31 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Medtronic, INC. | $204.28 | 2024-2025 | Minimed 780g |
| Boehringer Ingelheim Pharmaceuticals, INC. | $199.78 | 2019-2025 | Jardiance |
| Abbvie INC. | $192.89 | 2019-2025 | Synthroid |
| Alexion Pharmaceuticals, INC. | $170.33 | 2019-2025 | Strensiq |
| Sequel Med Tech, LLC | $166.67 | 2025 | Twiist |
| Cequr Corporation | $151.52 | 2023-2025 | Cequr Simplicity |
| Madrigal Pharmaceuticals | $137.25 | 2025 | Rezdiffra |
| Merck Sharp & Dohme LLC | $122.30 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $116.50 | 2024-2025 | |
| Recordati_rare_diseases_inc. | $108.16 | 2023-2025 | Isturisa, Signifor Lar |
| Mannkind Corporation | $107.90 | 2023-2025 | Afrezza |
| Ibsa Pharma INC. | $106.71 | 2019-2025 | Tirosint, Licart, Tirosint |
| Globus Medical, INC. | $105.74 | 2025 | Senza |
| Kyowa Kirin, INC. | $96.52 | 2024-2025 | Crysvita |
| Antares Pharma, INC. | $89.18 | 2019-2025 | Xyosted |
| Abbott Laboratories | $85.58 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx |
| Ascendis Pharma Endocrinology INC | $73.57 | 2024-2025 | Yorvipath |
| Amphastar Pharmaceuticals, INC. | $59.79 | 2024 | |
| Neurocrine Biosciences, INC. | $57.79 | 2025 | |
| Medtronic Minimed, INC. | $52.63 | 2019 | |
| Tolmar, INC. | $50.17 | 2023-2024 | |
| Shield Therapeutics INC | $48.21 | 2023-2024 | Accrufer |
| Astrazeneca Pharmaceuticals LP | $46.40 | 2019-2020 | |
| Shire North American Group INC | $45.72 | 2019 | |
| Avvisto Therapeutics, LLC | $40.63 | 2025 | Cycloset |
| Aegerion Pharmaceuticals, INC. | $32.75 | 2019 | |
| Sandoz INC. | $32.01 | 2025 | |
| Currax Pharmaceuticals LLC | $31.90 | 2024 | Contrave |
| Becton, Dickinson and Company | $27.82 | 2019 | |
| Grifols USA, LLC | $23.16 | 2025 | Gamunex-C |
| Nevro Corp. | $22.51 | 2024 | Senza |
| Medline Industries LP | $21.88 | 2025 | |
| Averitas Pharma INC. | $18.45 | 2024 | Qutenza |
| Pfizer INC. | $17.97 | 2024 | |
| Verity Pharmaceuticals INC. | $17.10 | 2024 | Tlando |
| Amryt Pharma Holdings LTD | $16.65 | 2023 | Mycapssa |
| Acella Pharmaceuticals, LLC | $16.11 | 2025 | NP Thyroid 60 |
| Glaxosmithkline, LLC. | $15.03 | 2025 | Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $12.87 | 2019 | |
| Halozyme INC | $12.79 | 2023 | |
| Gilead Sciences, INC. | $12.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.